TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer

NCT07047365 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
416
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.